Gene associated with retinoid-interferon-induced mortality-19 suppresses growth of lung adenocarcinoma tumor in vitro and in vivo

Lung Cancer

Volumn 72, Issue 3, 2011, Pages 287-293

  Wang, Tong ^a,b   Yan, Xue Bo ^a   Zhao, Ji Jing ^c   Ye, Jing ^a   Jiang, Zi Feng ^a   Wu, Dao Rong ^a   Xiao, Wei Hua ^d   Liu, Rong Yu ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b Hefei First People's Hospital   (China)

^c First Hospital of Jiande   (China)

^d UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

Adenocarcinoma; GRIM 19; Lung cancer; STAT3

Indexed keywords

CYCLIN B1; CYCLIN D1; MESSENGER RNA; PROTEIN BCL 2; STAT3 PROTEIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG ADENOCARCINOMA; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETINOID INTERFERON INDUCED MORTALITY 19 GENE; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ANIMALS; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH INHIBITORS; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; NADH, NADPH OXIDOREDUCTASES; PROTEIN BINDING; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ACTIVATION; TRANSGENES; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79955472010     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2010.10.001     Document Type: Article

References (34)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
2. Zhou Y., Li M., Wei Y., Feng D., Peng C., Weng H., et al. Down-regulation of GRIM-19 expression is associated with hyperactivation of STAT3-induced gene expression and tumor growth in human cervical cancers. J Interferon Cytokine Res 2009, 29:695-703.
3. Kalakonda S., Nallar S.C., Lindner D.J., Hu J., Reddy S.P., Kalvakolanu D.V. Tumor-suppressive activity of the cell death activator GRIM-19 on a constitutively active signal transducer and activator of transcription 3. Cancer Res 2007, 67:6212-6220.
4. Angell J.E., Lindner D.J., Shapiro P.S., Hofmann E.R., Kalvakolanu D.V. Identification of GRIM-19, a novel cell death-regulatory gene induced by the interferon-beta and retinoic acid combination, using a genetic approach. J Biol Chem 2000, 275:33416-33426.
5. Kalvakolanu D.V. The GRIMs: a new interface between cell death regulation and interferon/retinoid induced growth suppression. Cytokine Growth Factor Rev 2004, 15:169-194.
6. Yeh H.H., Lai W.W., Chen H.H., Liu H.S., Su W.C. Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion. Oncogene 2006, 25:4300-4309.
7. Buettner R., Mora L.B., Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 2002, 8:945-954.
8. Catlett-Falcone R., Dalton W.S., Jove R. STAT proteins as novel targets for cancer therapy Signal transducer an activator of transcription. Curr Opin Oncol 1999, 11:490-496.
9. Sanchez-Ceja S.G., Reyes-Maldonado E., Vazquez-Manriquez M.E., Lopez-Luna J.J., Belmont A., Gutierrez-Castellanos S. Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma. Lung Cancer 2006, 54:163-168.
10. Zhang X., Zhang J., Wang L., Wei H., Tian Z. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice. BMC Cancer 2007, 7:149.
11. Lufei C., Ma J., Huang G., Zhang T., Novotny-Diermayr V., Ong C.T., et al. GRIM-19, a death-regulatory gene product, suppresses Stat3 activity via functional interaction. EMBO J 2003, 22:1325-1335.
12. Puthier D., Bataille R., Amiot M. IL-6 up-regulates mcl-1 in human myeloma cells through JAK/STAT rather than ras/MAP kinase pathway. Eur J Immunol 1999, 29:3945-3950.
13. Niu G., Wright K.L., Huang M., Song L., Haura E., Turkson J., et al. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 2002, 21:2000-2008.
14. Xie T.X., Wei D., Liu M., Gao A.C., Ali-Osman F., Sawaya R., et al. Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene 2004, 23:3550-3560.
15. Maximo V., Botelho T., Capela J., Soares P., Lima J., Taveira A., et al. Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid. Br J Cancer 2005, 92:1892-1898.
16. Zhang L., Gao L., Li Y., Lin G., Shao Y., Ji K., et al. Effects of plasmid-based Stat3-specific short hairpin RNA and GRIM-19 on PC-3M tumor cell growth. Clin Cancer Res 2008, 14:559-568.
17. Alchanati I., Nallar S.C., Sun P., Gao L., Hu J., Stein A., et al. A proteomic analysis reveals the loss of expression of the cell death regulatory gene GRIM-19 in human renal cell carcinomas. Oncogene 2006, 25:7138-7147.
18. Lu Y., Fukuyama S., Yoshida R., Kobayashi T., Saeki K., Shiraishi H., et al. Loss of SOCS3 gene expression converts STAT3 function from anti-apoptotic to pro-apoptotic. J Biol Chem 2006, 281:36683-36690.
19. Gerdes J., Li L., Schlueter C., Duchrow M., Wohlenberg C., Gerlach C., et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991, 138:867-873.
20. Bowman T., Garcia R., Turkson J., Jove R. STATs in oncogenesis. Oncogene 2000, 19:2474-2488.
21. Bromberg J.F., Wrzeszczynska M.H., Devgan G., Zhao Y., Pestell R.G., Albanese C., et al. Stat3 as an oncogene. Cell 1999, 98:295-303.
22. Inghirami G., Chiarle R., Simmons W.J., Piva R., Schlessinger K., Levy D.E. New and old functions of STAT3: a pivotal target for individualized treatment of cancer. Cell Cycle 2005, 4:1131-1133.
23. Lu H., Cao X. GRIM-19 is essential for maintenance of mitochondrial membrane potential. Mol Biol Cell 2008, 19:1893-1902.
24. Reeves M.B., Davies A.A., McSharry B.P., Wilkinson G.W., Sinclair J.H. Complex I binding by a virally encoded RNA regulates mitochondria-induced cell death. Science 2007, 316:1345-1348.
25. Papa F., Delia M., Trentadue R., Panelli D., Bellomo F., Serpico R., et al. Differential effects of all-trans retinoic acid on the growth of human keratinocytes and mouth carcinoma epidermoid cultures. Involvement of GRIM-19 and complex I of the respiratory chain. Int J Immunopathol Pharmacol 2007, 20:719-729.
26. Fearnley I.M., Carroll J., Shannon R.J., Runswick M.J., Walker J.E., Hirst J. GRIM-19, a cell death regulatory gene product, is a subunit of bovine mitochondrial NADH:ubiquinone oxidoreductase (complex I). J Biol Chem 2001, 276:38345-38348.
27. Lotan R., Dawson M.I., Zou C.C., Jong L., Lotan D., Zou C.P. Enhanced efficacy of combinations of retinoic acid- and retinoid X receptor-selective retinoids and alpha-interferon in inhibition of cervical carcinoma cell proliferation. Cancer Res 1995, 55:232-236.
28. Zhang J., Yang J., Roy S.K., Tininini S., Hu J., Bromberg J.F., et al. The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3. Proc Natl Acad Sci U S A 2003, 100:9342-9347.
29. Juttner S., Wissmann C., Jons T., Vieth M., Hertel J., Gretschel S., et al. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma. J Clin Oncol 2006, 24:228-240.
30. Xu Q., Briggs J., Park S., Niu G., Kortylewski M., Zhang S., et al. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene 2005, 24:5552-5560.
31. Schaefer L.K., Ren Z., Fuller G.N., Schaefer T.S. Constitutive activation of Stat3alpha in brain tumors: localization to tumor endothelial cells and activation by the endothelial tyrosine kinase receptor (VEGFR-2). Oncogene 2002, 21:2058-2065.
32. Mook O.R., Frederiks W.M., Van Noorden C.J. The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta 2004, 1705:69-89.
33. Wu J., Akaike T., Hayashida K., Okamoto T., Okuyama A., Maeda H. Enhanced vascular permeability in solid tumor involving peroxynitrite and matrix metalloproteinases. Jpn J Cancer Res 2001, 92:439-451.
34. Gross A., McDonnell J.M., Korsmeyer S.J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev 1999, 13:1899-1911.